Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
33.43
-0.10 (-0.30%)
At close: Sep 18, 2025, 4:00 PM EDT
33.19
-0.24 (-0.72%)
After-hours: Sep 18, 2025, 4:54 PM EDT
Company Description
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms.
The company’s molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment.
It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers.
The company was founded in 2008 and is headquartered in Irving, Texas.
Caris Life Sciences, Inc.
| Country | United States |
| Founded | 2008 |
| IPO Date | Jun 18, 2025 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1,769 |
| CEO | David Halbert |
Contact Details
Address: 750 West John Carpenter Freeway, Suite 800 Irving, Texas 75039 United States | |
| Phone | 866 771 8946 |
| Website | carislifesciences.com |
Stock Details
| Ticker Symbol | CAI |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $21.00 |
| CIK Code | 0002019410 |
| ISIN Number | US1421521071 |
| Employer ID | 85-2077369 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Dr. David Dean Halbert M.D. | Chairman, Chief Executive Officer and Founder |
| Brian J. Brille J.D. | Executive Vice Chairman and Executive Vice President |
| Dr. David Spetzler M.B.A., M.S., MBA, MS, Ph.D. | President |
| Luke Power | Senior Vice President, Chief Financial Officer and Chief Accounting Officer |
| Jon Mark Harmon | Senior Vice President and Chief Operations Officer |
| Dr. Valeriy Domenyuk | Senior Vice President and Chief Technology Officer |
| Dr. Milan Radovich Ph.D. | Senior Vice President and Chief Scientific Officer |
| Ginger Appleberry J.D. | Senior Vice President, Deputy General Counsel and Chief Compliance Officer |
| J. Russel Denton | Senior Vice President, General Counsel and Secretary |
| Narendra Chokshi | Senior Vice President of Corporate Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 14, 2025 | SCHEDULE 13G | Filing |
| Aug 13, 2025 | SCHEDULE 13G | Filing |
| Aug 12, 2025 | 10-Q | Quarterly Report |
| Aug 12, 2025 | 8-K | Current Report |
| Jul 28, 2025 | SCHEDULE 13G | Filing |
| Jun 24, 2025 | SCHEDULE 13G | Filing |
| Jun 20, 2025 | 8-K | Current Report |
| Jun 20, 2025 | 424B4 | Prospectus |
| Jun 18, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jun 17, 2025 | EFFECT | Notice of Effectiveness |